GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (STU:7ZT) » Definitions » 5-Year ROIIC %

Hamlet BioPharma AB publ (STU:7ZT) 5-Year ROIIC % : -59.18% (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Hamlet BioPharma AB publ 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Hamlet BioPharma AB publ's 5-Year ROIIC % for the quarter that ended in Jun. 2024 was -59.18%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Hamlet BioPharma AB publ's 5-Year ROIIC % or its related term are showing as below:

STU:7ZT's 5-Year ROIIC % is ranked worse than
61.34% of 1301 companies
in the Biotechnology industry
Industry Median: -22.17 vs STU:7ZT: -59.18

Hamlet BioPharma AB publ 5-Year ROIIC % Historical Data

The historical data trend for Hamlet BioPharma AB publ's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ 5-Year ROIIC % Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,992.78 -36.14 -335.08 -40.54 -59.18

Hamlet BioPharma AB publ Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -59.18 -

Competitive Comparison of Hamlet BioPharma AB publ's 5-Year ROIIC %

For the Biotechnology subindustry, Hamlet BioPharma AB publ's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's 5-Year ROIIC % falls into.



Hamlet BioPharma AB publ 5-Year ROIIC % Calculation

Hamlet BioPharma AB publ's 5-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( -3.768 (Jun. 2024) - -1.609 (Jun. 2019) )/( 3.903 (Jun. 2024) - 0.102 (Jun. 2019) )
=-2.159/3.801
=-56.80%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Hamlet BioPharma AB publ  (STU:7ZT) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Hamlet BioPharma AB publ 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Comparable Companies
Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines